PMID- 21956423 OWN - NLM STAT- MEDLINE DCOM- 20120209 LR - 20220309 IS - 1945-7197 (Electronic) IS - 0021-972X (Print) IS - 0021-972X (Linking) VI - 96 IP - 12 DP - 2011 Dec TI - Circulating concentrations of monocyte chemoattractant protein-1, plasminogen activator inhibitor-1, and soluble leukocyte adhesion molecule-1 in overweight/obese men and women consuming fructose- or glucose-sweetened beverages for 10 weeks. PG - E2034-8 LID - 10.1210/jc.2011-1050 [doi] AB - CONTEXT: Results from animal studies suggest that consumption of large amounts of fructose can promote inflammation and impair fibrinolysis. Data describing the effects of fructose consumption on circulating levels of proinflammatory and prothrombotic markers in humans are unavailable. OBJECTIVE: Our objective was to determine the effects of 10 wk of dietary fructose or glucose consumption on plasma concentrations of monocyte chemoattractant protein-1 (MCP-1), plasminogen activator inhibitor-1 (PAI-1), E-selectin, intercellular adhesion molecule-1, C-reactive protein, and IL-6. DESIGN AND SETTING: This was a parallel-arm study with two inpatient phases (2 wk baseline, final 2 wk intervention), conducted in a clinical research facility, and an outpatient phase (8 wk) during which subjects resided at home. PARTICIPANTS: Participants were older (40-72 yr), overweight/obese (body mass index = 25-35 kg/m(2)) men (n = 16) and women (n = 15). INTERVENTIONS: Participants consumed glucose- or fructose-sweetened beverages providing 25% of energy requirements for 10 wk. Blood samples were collected at baseline and during the 10th week of intervention. MAIN OUTCOME MEASURES: Fasting concentrations of MCP-1 (P = 0.009), PAI-1 (P = 0.002), and E-selectin (P = 0.048) as well as postprandial concentrations of PAI-1 (P < 0.0001) increased in subjects consuming fructose but not in those consuming glucose. Fasting levels of C-reactive protein, IL-6, and intercellular adhesion molecule-1 were not changed in either group. CONCLUSIONS: Consumption of fructose for 10 wk leads to increases of MCP-1, PAI-1, and E-selectin. These findings suggest the possibility that fructose may contribute to the development of the metabolic syndrome via effects on proinflammatory and prothrombotic mediators. FAU - Cox, Chad L AU - Cox CL AD - Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, One Shields Avenue, Davis, California 95616, USA. FAU - Stanhope, Kimber L AU - Stanhope KL FAU - Schwarz, Jean Marc AU - Schwarz JM FAU - Graham, James L AU - Graham JL FAU - Hatcher, Bonnie AU - Hatcher B FAU - Griffen, Steven C AU - Griffen SC FAU - Bremer, Andrew A AU - Bremer AA FAU - Berglund, Lars AU - Berglund L FAU - McGahan, John P AU - McGahan JP FAU - Keim, Nancy L AU - Keim NL FAU - Havel, Peter J AU - Havel PJ LA - eng SI - ClinicalTrials.gov/NCT01165853 GR - HL-091333/HL/NHLBI NIH HHS/United States GR - K23 DK097307/DK/NIDDK NIH HHS/United States GR - AT-003545/AT/NCCIH NIH HHS/United States GR - UL1 RR024146/RR/NCRR NIH HHS/United States GR - R01 HL075675/HL/NHLBI NIH HHS/United States GR - R01 HL091333/HL/NHLBI NIH HHS/United States GR - R01 HL-075675/HL/NHLBI NIH HHS/United States GR - DK-097307/DK/NIDDK NIH HHS/United States GR - R01 HL107256/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20110928 PL - United States TA - J Clin Endocrinol Metab JT - The Journal of clinical endocrinology and metabolism JID - 0375362 RN - 0 (Blood Glucose) RN - 0 (Chemokine CCL2) RN - 0 (E-Selectin) RN - 0 (Plasminogen Activator Inhibitor 1) RN - 0 (Sweetening Agents) RN - 126547-89-5 (Intercellular Adhesion Molecule-1) RN - 126880-86-2 (L-Selectin) RN - 30237-26-4 (Fructose) RN - 9007-41-4 (C-Reactive Protein) RN - IY9XDZ35W2 (Glucose) SB - IM MH - Adult MH - Aged MH - Beverages MH - Blood Glucose/metabolism MH - C-Reactive Protein/metabolism MH - Chemokine CCL2/*blood MH - E-Selectin/blood MH - Female MH - Fructose/*administration & dosage MH - Glucose/*administration & dosage MH - Humans MH - Intercellular Adhesion Molecule-1/blood MH - L-Selectin/*blood MH - Male MH - Middle Aged MH - Obesity/*blood MH - Overweight/*blood MH - Plasminogen Activator Inhibitor 1/*blood MH - Postprandial Period/drug effects/physiology MH - Sweetening Agents/administration & dosage PMC - PMC3232623 EDAT- 2011/10/01 06:00 MHDA- 2012/02/10 06:00 PMCR- 2012/12/01 CRDT- 2011/09/30 06:00 PHST- 2011/09/30 06:00 [entrez] PHST- 2011/10/01 06:00 [pubmed] PHST- 2012/02/10 06:00 [medline] PHST- 2012/12/01 00:00 [pmc-release] AID - jc.2011-1050 [pii] AID - 11-1050 [pii] AID - 10.1210/jc.2011-1050 [doi] PST - ppublish SO - J Clin Endocrinol Metab. 2011 Dec;96(12):E2034-8. doi: 10.1210/jc.2011-1050. Epub 2011 Sep 28.